ReleaseWire Connect

Foot-and-mouth disease (FMD) is an infection caused by aphthovirus belonging to the family Picornaviridae. FMD is caused by seven different types of serotypes: O, A, C, Asia 1 and Southern African Territories (SAT) 1, 2 and 3. Currently available vaccines are serotype-specific, hence multiple vaccinations are required to cover the antigenic diversity. Cloven-hoofed animals especially cattle, pigs, sheep and goats are susceptible to FMD. The major symptoms of FMD are high fever, sudden weight loss, increased death rate in newborn animals, low conception rate, painful lesions in and around mouth, lips and feet, and excessive salivation. High frequency of FMD outbreaks especially in Asia, the Middle East, and Latin America is fueling the demand for FMD vaccines. In addition, government initiatives to eradicate the disease is resulting in increased awareness about FMD vaccines, thereby driving market growth. This report covers the market analysis of various types of vaccines that are used to control FMD.

Chemotherapy induced nausea and vomiting (CINV) refers to the nausea and vomiting associated with cancer chemotherapy. Various sources indicate that approximately 70% to 80% cancer patients undergoing chemotherapy exhibit nausea and vomiting as major symptoms. Chemotherapy induced nausea and vomiting is an extremely debilitating condition. Although there are currently a number of drugs available to manage CINV, they do not effectively address the symptoms of this condition. The report on CINV existing and pipeline drugs market offers an insightful and in-depth assessment of the current as well as future market potential of CINV drugs. Aloxi (palonosetron), Zofran generic (ondansetron), Kytril generic (granisetron), Emend (aprepitant) and Akynzeo (netupitant-palonosetron FDC) are the major currently available drugs extensively studied in the report.

This would hamper the growth of the market. The global mouth ulcers treatment market was valued at USD 1,242.6 million in 2013 and is expected to reach an estimated value of USD 1,596.9 million in 2020, growing at a CAGR of 3.8% from 2014 to 2020.

The global blood pressure monitoring testing market was valued at USD 1,713.3 million in 2012 and is expected to grow at a CAGR of 11.5% from 2013 to 2019, to reach an estimated value of USD 3,661.3 million by 2019.

Since its introduction over a decade ago, 3D printing as a technology has revolutionized manufacturing as a process. Ever increasing cost pressures on medical device manufacturers and their intense need to introduce innovative products has forced them to adopt 3D printing as a means to reduce the manufacturing life cycle and almost completely eliminate the traditional prototyping process. Traditional manufacturing techniques are based on the subtractive method where, the required product is created by cutting or drilling of the base material. 3D printing builds the desired products layer-by-layer through addition of materials. Hence, this process is also called as additive manufacturing. Although, 3D printing is actually a subset of additive manufacturing, it used synonymously with additive manufacturing in the industry. The overall 3D printing market for medical applications has been categorized on the basis of its applications, raw materials, and technology.

Micro-Electro-Mechanical Systems, MEMS is defined as devices made up of miniaturized mechanical and electromechanical elements using micro fabrication techniques. MEMS comprises of miniaturized structures such as sensors, actuators and microelectronics. The prime elements are micro sensors and micro actuators. These are also called as transducers which help in conversion of one form of the energy into another. Technological advances have led to development of a synergistic relation between the unrelated fields such as biology and microelectronics. MEMS finds its application in medical sector especially diagnosis and biotechnology. There has been a paradigm shift of patient taking treatment from hospital to home care.

Exponential growth is being witnessed by the global cell surface markers market owing to ease of data management and automation of solutions and technologies. The increased occurrence of chronic diseases, particularly autoimmune disorders and cancer, has stimulated the demand for cell surface markers globally.

The report provides forecast and analysis of the micronutrients market on a global and regional level. The study provides historical data of 2013 along with forecast from 2014 to 2020 based on volumes (Kilo Tons) and revenue (USD Million). The report includes drivers and restraints for the micronutrients market along with their impact on demand during the forecast period. Additionally, the report comprises an analysis of opportunities available in the micronutrients market on the global and regional level. The drivers, restraints and opportunities mentioned in the report are justified with the help of quantitative and qualitative data which is verified by primary and secondary resources.

Antimicrobial plastics are molded polymers infused with antimicrobials to inhibit the growth of various harmful microorganisms such as fungi and bacteria. Antimicrobial plastics are used in various industries such as healthcare, automotives, building & construction, electronics, packaging and consumer goods. Additionally, they are used in niche applications such as pipes, plastic water storage containers, waste bins and lids. Rising awareness among consumers regarding good health and cleanliness is expected to be one of the primary factors driving the growth of the antimicrobial plastics market.

Carbon black is a finely divided black colored powder produced by thermal decomposition or incomplete combustion of hydrocarbons such as natural gas, coal gas and petroleum oil. It is produced as black-colored colloidal particles through processes such as furnace black process, channel process and acetylene process. Carbon black is primarily used as a dyeing agent in the textile industry.